OPKO Health
OPK
$1.37
Share price
-2.84%
Change (1 day)
-2.14%
Change (1 year)
Categories
OPKO Health (OPK) - Total debt
Total debt on the balance sheet as of March 2024 : $0.41 B
According to OPKO Health 's latest financial reports the company's total debt is $0.41 B. A company’s total debt is the sum of all current and non-current debts.
OPKO Health - Total debt on balance sheet (from 2001 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.32 B | 6.88% |
| 2022-12-31 | $0.30 B | 19.94% |
| 2021-12-31 | $0.25 B | -13.52% |
| 2020-12-31 | $0.29 B | -6.77% |
| 2019-12-31 | $0.31 B | 48.02% |
| 2018-12-31 | $0.21 B | 35.11% |
| 2017-12-31 | $0.15 B | 49.83% |
| 2016-12-31 | $0.10 B | -29.58% |
| 2015-12-31 | $0.14 B | 1.63% |
| 2014-12-31 | $0.14 B | -35.3% |
| 2013-12-31 | $0.22 B | 904.34% |
| 2012-12-31 | $22.67 M | 158.95% |
| 2011-12-31 | $8.75 M | -40.39% |
| 2010-12-31 | $14.69 M | -25.29% |
| 2009-12-31 | $19.66 M | 42.58% |
| 2008-12-31 | $13.79 M | -3.13% |
| 2007-12-31 | $14.23 M | |
| 2002-12-31 | $0.2 M | 0% |
| 2001-12-31 | $0.2 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $33.63 B | 7,915.69% | 🇺🇸 USA |
 Abbott Laboratories ABT | $14.58 B | 3,376.36% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $2.70 B | 544.29% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $57.40 B | 13,582.59% | 🇺🇸 USA |
 LabCorp LH | $5.96 B | 1,322.50% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $1.30 B | 210.13% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $19.93 B | 4,651.93% | 🇮🇱 Israel |
 Ardelyx ARDX | $0.10 B | -74.99% | 🇺🇸 USA |